Q4 2025 Myomo Inc Earnings Call Transcript
Key Points
- Myomo Inc (MYO) reported a 26% revenue growth for the full year 2025, reaching $40.9 million.
- The company achieved its highest revenue quarter in Q4 2025 with $11.4 million, driven by expanded penetration of the orthotics and prosthetics (O&P) channel and international revenues.
- The MyoConnect referral program showed early success, contributing to a 52% year-over-year growth in revenue from recurring sources.
- International operations delivered quarterly revenues exceeding $2 million for the first time, growing 46% for the quarter and 48% for the year.
- Myomo Inc (MYO) signed a multistate agreement with Elevance Health, expanding market access and streamlining the authorization process for patients.
- Revenue for Q4 2025 was down slightly compared to the prior year period due to a lower number of revenue units and a slightly lower average selling price.
- The company faced challenges with Medicare Advantage payers, resulting in a high number of pre-authorization denials and necessitating an appeals process.
- Direct billing revenue was down 20% year-over-year due to lower Medicare and Medicare Advantage authorizations.
- Operating expenses for Q4 2025 increased by 19% over the prior year quarter, driven by higher sales, clinical, and marketing expenses.
- Net loss for Q4 2025 was $3.8 million, compared to a net loss of $300,000 in the prior year quarter, with adjusted EBITDA turning negative.
Good day, and welcome to the Myomo Fourth Quarter and Full Year 2025 Financial Results. (Operator Instructions) Please note, this event is being recorded.
I will now turn the conference over to Mr. Tirth Patel with Alliance Advisors IR. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone. This is Tirth Patel with Alliance Advisors IR. Welcome to the Myomo fourth quarter and full year 2025 financial results conference call. With me on today's call are Myomo's Chief Executive Officer, Paul Gudonis; and Chief Financial Officer, Dave Henry.
Before we begin, I'd like to caution listeners that statements made during this call by management, other than historical facts, are forward-looking statements. The words anticipate, believe, estimate, expect, intend, guidance, outlook, confidence, targets, project, and other similar expressions are typically used to identify such forward-looking statements. These forward-looking statements are not guarantees
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
